FDA approves Ebanga for the treatment of Ebola
by Press Release from Outbreak News Today on (#5CZ5Z)
By News Desk @bactiman63 Biotechnology company, Ridgeback Biotherapeutics, announced recently that the U.S. Food and Drug Administration (FDA) approved EbangaTM for the treatment of Ebola. Ebanga is now approved for treatment of infection caused by Zaire ebolavirus in adult and pediatric patients (including neonates born to a mother who is RT-PCR positive for Zaire ebolavirus infection). Ebanga is the only FDA [...]
The post FDA approves Ebanga for the treatment of Ebola appeared first on Outbreak News Today.